NASDAQ:AMED
Amedisys Inc Stock News
$94.43
-0.520 (-0.548%)
At Close: May 17, 2024
Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
04:15pm, Wednesday, 23'rd Dec 2020
BATON ROUGE, La., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice and personal care company, today announced that its Board of Direc
Amedisys (AMED) Down 5.5% Since Last Earnings Report: Can It Rebound?
11:31am, Friday, 27'th Nov 2020
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Amedisys to Present at the Jefferies Virtual London Healthcare Conference
04:30pm, Monday, 16'th Nov 2020
BATON ROUGE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Pre
Amedisys to Present at the Stephens Annual Investment Conference 2020
04:00pm, Tuesday, 10'th Nov 2020
BATON ROUGE, La., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, P
Amedisys to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
04:00pm, Thursday, 05'th Nov 2020
BATON ROUGE, La., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Pre
Amedisys, Inc.'s (AMED) CEO Paul Kusserow on Q3 2020 Results - Earnings Call Transcript
01:42pm, Thursday, 29'th Oct 2020
Amedisys, Inc.'s (AMED) CEO Paul Kusserow on Q3 2020 Results - Earnings Call Transcript
Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone
11:00am, Thursday, 29'th Oct 2020
After a 82% rise since the March 16 lows of this year, at the current price of around $249 per share we believe Amedisys stock, a home health and hospice care company, has reached its near-term potent
Amedisys: Q3 Earnings Insights
04:38pm, Wednesday, 28'th Oct 2020
Shares of Amedisys (NASDAQ:AMED) fell 2.7% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 94.78% year over year to $2.24, which beat the estim
Amedisys Reports Third Quarter 2020 Financial Results - Updates 2020 Guidance
04:05pm, Wednesday, 28'th Oct 2020
BATON ROUGE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2020.
Vestmark Advisory Solutions Inc. Has $649,000 Position in Amedisys Inc (NASDAQ:AMED)
07:10am, Thursday, 22'nd Oct 2020
Vestmark Advisory Solutions Inc. grew its holdings in Amedisys Inc (NASDAQ:AMED) by 30.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional i
Financial Contrast: Cancer Treatment (OTCMKTS:CTHZ) and Amedisys (OTCMKTS:AMED)
07:20am, Sunday, 18'th Oct 2020
Cancer Treatment (OTCMKTS:CTHZ) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recomme
Exane Derivatives Buys Shares of 364 Amedisys Inc (NASDAQ:AMED)
08:10am, Thursday, 08'th Oct 2020
Exane Derivatives bought a new stake in Amedisys Inc (NASDAQ:AMED) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor b
Three Oaks Hospice Selects Hospice Pharmacy Solutions® as PBM Partner
12:00am, Thursday, 08'th Oct 2020
Three Oaks Hospice has joined Hospice Pharmacy Solutions’ Tru360 program and its national network of community-based pharmacies to improve financial
Queen City Hospice Expands to Cleveland
12:00am, Wednesday, 30'th Sep 2020
Queen City Hospice LLC expands to Cleveland where it will serve the Greater Cleveland area as Miracle City Hospice.
